REQUEST A DEMO
Total
USD $0.00
Search more companies

TJ Pharm Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: TJ Pharm Co.,Ltd. Profile Updated: October 23, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

TJ Pharm Co.,Ltd. is an enterprise based in South Korea. Its main office is in Pyeongtaek. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on November 02, 2005. 292 (2023) employees currently work for TJ Pharm Co.,Ltd.. There was a net sales revenue increase of 15.72% reported in TJ Pharm Co.,Ltd.’s latest financial highlights for 2022. A growth of 11.37% was recorded in its total assets. In, 2022, the company’s net profit margin increased by 0.11%.

Headquarters
2038, Gyeonggi-daero Jinwi-myeon Pyeongtaek-si Gyeonggi
Pyeongtaek; Gyeonggi; Postal Code: 451862

Contact Details: Purchase the TJ Pharm Co.,Ltd. report to view the information.

Website: http://www.taejeongroup.com

Basic Information
Total Employees:
Purchase the TJ Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the TJ Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the TJ Pharm Co.,Ltd. report to view the information.
Incorporation Date:
November 02, 2005
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
41.1%
Purchase this report to view the information.
25.6%
Purchase this report to view the information.
18.3%
Subsidiaries
Taejeon Pharmaceutical Wholesale Co.,Ltd.
Tjhc Co.,Ltd.
Company Performance
Financial values in the chart are available after TJ Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
15.72%
Total operating revenue
15.72%
Operating profit (EBIT)
29.94%
EBITDA
27.07%
Net Profit (Loss) for the Period
46.66%
Total assets
11.37%
Total equity
8.44%
Operating Profit Margin (ROS)
0.11%
Net Profit Margin
0.11%
Return on Equity (ROE)
1.97%
Debt to Equity Ratio
1.81%
Quick Ratio
-0.05%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?